International Journal of Pharmaceutical Investigation logo
Review

An Overview of a Biomarker in Breast Cancer

1, 1, 1, 1, 1, 1, 1★★ Corresponding author

  1. 1Department of Pharmaceutics, JSS College of Pharmacy, Mysuru, JSS Academy of Higher Education and Research, Sri Shivarathreeshwara Nagar, Mysuru, Karnataka, INDIA.

CORRESPONDENCE

Shailesh T

Department of Pharmaceutics, JSS College of Pharmacy, Mysuru, JSS Academy of Higher Education and Research, Sri Shivarathreeshwara Nagar, Mysuru, Karnataka, INDIA.

shailesht@jssuni.edu.in

Received: 21-04-2023; Revised: 10-05-2023; Accepted: 01-06-2023.

Volume 13, Issue 4 · pp. 721-734 · 2023 · DOI: 10.5530/ijpi.13.4.090

ABSTRACT

Cancer is one of the leading causes of death across the world, which is caused by tumours. Breast Cancer (BC) is the most common cancer in women and the second most common cancer death in women. A variety of molecular biomarkers are being used to predict BC susceptibility, including hormone receptors for subtyping and several genes involved in genome maintenance. Hence, biomarkers have specific importance in translational and clinical development to improve diagnosis, prognosis, and treatment since they have advantages in detection time and energy efficiency. The impact of breast cancer, as well as BC risk factors, identification of high-risk groups, screening modalities, and guidelines for screening average-risk and high-risk individuals, therapy advancement using various types of biomarkers. This review describes the design, approval, and distribution of biomarkers and outlines the many types of biomarkers currently used in breast cancer.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Akhila, G., AG, N., KM, A. S., S, H. K., HS, H., R, V. V., & T, S. (2023). An Overview of a Biomarker in Breast Cancer. International Journal of Pharmaceutical Investigation, 13(4), 721-734. https://doi.org/10.5530/ijpi.13.4.090

    Copyright and licence

    © 2023 Author(s)

    This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. CC BY-NC-SA 4.0